Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Immunocore Holdings (IMCR) Shares Outstanding (Weighted Average): 2021-2025

Historic Shares Outstanding (Weighted Average) for Immunocore Holdings (IMCR) over the last 3 years, with Sep 2025 value amounting to $50.4 million.

  • Immunocore Holdings' Shares Outstanding (Weighted Average) rose 0.74% to $50.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $50.4 million, marking a year-over-year increase of 0.74%. This contributed to the annual value of $50.0 million for FY2024, which is 1.20% up from last year.
  • Latest data reveals that Immunocore Holdings reported Shares Outstanding (Weighted Average) of $50.4 million as of Q3 2025, which was up 0.31% from $50.2 million recorded in Q2 2025.
  • In the past 5 years, Immunocore Holdings' Shares Outstanding (Weighted Average) registered a high of $50.4 million during Q3 2025, and its lowest value of $43.9 million during Q4 2021.
  • In the last 3 years, Immunocore Holdings' Shares Outstanding (Weighted Average) had a median value of $50.0 million in 2024 and averaged $49.6 million.
  • Data for Immunocore Holdings' Shares Outstanding (Weighted Average) shows a peak YoY increased of 9.22% (in 2022) over the last 5 years.
  • Over the past 5 years, Immunocore Holdings' Shares Outstanding (Weighted Average) (Quarterly) stood at $43.9 million in 2021, then grew by 9.22% to $47.9 million in 2022, then increased by 3.20% to $49.4 million in 2023, then climbed by 1.20% to $50.0 million in 2024, then increased by 0.74% to $50.4 million in 2025.
  • Its Shares Outstanding (Weighted Average) stands at $50.4 million for Q3 2025, versus $50.2 million for Q2 2025 and $50.1 million for Q1 2025.